With a unique approach that draws on 3-D printing technologies, a team of University of Wisconsin-Madison researchers is developing new tools for understanding how ovarian cancer develops in women.About 1.5 percent of American women will be diagnosed with ovarian cancer, … Read more
A new joint clinical practice guideline from the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) states that neoadjuvant chemotherapy (NACT) is the optimal first-line treatment for some women who have newly diagnosed advanced ovarian … Read more
Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results, published in two journals, provide new research routes for scientists trying to detect … Read more
Commentary about ‘The Improvisational Oncologist’ written by The Clearity Foundation’s founder, Dr. Laura Shawver:
Dr. Mukhergee’s article, ‘The Improvisational Oncologist’, in the New York Times Magazine hits our mission at The Clearity Foundation front and center. He remarks that, “every … Read more
By: Annette McElhiney
Nemesis is defined as, “the inescapable agent of someone’s or something’s downfall.” This word seems perfect to characterize neuropathy as for many people with post chemo neuropathy, the condition literally causes us to take numerous, unwanted falls.… Read more
Government scientists are seeking a million volunteers willing to share the innermost secrets of their genes and daily lives as part of an ambitious 10-year research project to understand the causes and cures of disease.
Those selected to be members … Read more
The University of California, San Francisco announced last week that the California Initiative to Advance Precision Medicine (CIAPM) will provide $7.2 million in new funding to support to new precision medicine research projects.
The CIAPM was established in 2015 with … Read more
Simplifying the way ovarian patients are tested is a “win-win” that saves both lives and money, a study shows. Testing their DNA should identify the most effective drugs and finds out if other family members are at risk.
Fewer than … Read more
By: Annette McElhiney
Nearly everyone has heard the term Precision Medicine. However most of us have only a shallow understanding of what precision medicine means. To fully understand, go to the government web site and read the President’s initiative in … Read more
Over the past 20 years, Nazneen Rahman has identified a steady stream of genes that influence the risk of breast, ovarian, and childhood cancers—work that has earned her scientific, popular, and even royal acclaim. But her latest accomplishment, and one … Read more
Promising new therapies are springing up to treat ovarian cancer, long one of the most deadly and hard to treat malignancies. The latest: An experimental drug from Tesaro, a small biotech company based in Waltham, Mass. The company on Wednesday … Read more
With the number of cancer survivors growing every day, the question of what to eat after a cancer diagnosis is quickly becoming a hot topic. Some survivors believe it is of little importance: they have already been through cancer, so … Read more
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Phase 3 NOVA trial of niraparib successfully achieved its primary endpoint of progression-free survival (PFS). This trial demonstrated that niraparib significantly prolonged PFS compared to control among patients who … Read more
By: Annette McElhiney
“Resilience presents a challenge for psychologists. Whether you can be said to have it or not largely depends not on any particular psychological test but on the way your life unfolds. If you are lucky enough to … Read more
Lack of exercise is associated with an increased risk of ovarian cancer and of death from the disease, two new studies suggest. “Women may be overwhelmed with mixed messages about physical activity or exercise recommendations and opt to be inactive
… Read moreYou’ve probably heard the adage that you are more likely to regret the things you didn’t do than the things you did. Maybe there’s a long lost love that got away, a career you wish you had pursued, a trip
… Read moreIncreased collaboration and a willingness to see beyond the expected will be critical to the success of the national cancer moonshot initiative, Vice President Joe Biden told ASCO Annual Meeting attendees this afternoon. “No single oncologist or cancer researcher can … Read more
ASCO’s (American Society of Clinical Oncology) Annual Meeting was held on June 2nd through June 7th in Chicago, Illinois. ASCO offers premier scientific events for oncology professionals, patients, patient advocates, industry representatives, and major media outlets worldwide. It showcased new … Read more
Inside each ovarian tumor, there are good cells and bad cells. A new paper explains their roles: The bad cells are fibroblasts. They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment. … Read more
By: Annette McElhiney
I’ve mentioned frequently, I’m not a medical doctor or a scientific researcher. I’m simply a former nurse, retired college English and Womens Studies Professor, and an 8-year survivor of IIIC ovarian cancer who wants to improve my … Read more
